Powerful Approach for New Drugs as Antibacterial Agents via Molecular Docking and In Vitro Studies of Some New Cyclic Imides and Quinazoline-2,5-diones

Abstract

We generated novel elven 1,2,3,6-tetrahydrophthalimides and tetrahydroquinazoline derivatives from 1,2,3,6-tetrahydrophthalic anhydride (<b>1</b>) in response to our interest in using the anhydrides to produce heterocyclic nitrogen compounds. The elemental and spectral analyses of the produced compounds validated the recommended configurations and <b>MOE 2014.09</b> (Molecular Operating Environment) computations were used to perform their in silico analysis. The synthesized compounds have been analyzed and put through various experiments, including in vitro and in silico methods to assess their biological activity against <i>Escherichia coli</i> Penicillin-Binding Protein 3 (<b>PBP3</b>) and <i>Staphylococcus aureus</i> Penicillin-Binding Protein 2 (<b>PBP2</b>), among these compounds showing promising data as antibacterial drugs.